Two pathogenetic types of endometrial carcinoma - PubMed
Two pathogenetic types of endometrial carcinoma
J V Bokhman. Gynecol Oncol. 1983 Feb.
Abstract
The author presents a hypothesis that the complex of endocrine and metabolic disturbances arising long before the development of endometrial carcinoma determines the biological peculiarities of the tumor, its clinical course, and the prognosis of the disease. On the basis of a prospective study of 366 patients with endometrial carcinoma, the author postulates that there are two different pathogenetic types of endometrial carcinoma. The first pathogenetic type of the disease arises in women with obesity, hyperlipidemia, and signs of hyperestrogenism: anovulatory uterine bleeding, infertility, late onset of the menopause, and hyperplasia of the stroma of the ovaries and endometrium. The second pathogenetic type of the disease arises in women who have no signs stated above or these signs are not clearly defined. The frequency of the first pathogenetic type in the studied group of women was 65%, whereas the frequency of the second type was 35%. The peculiarities outlined above which are characteristic of the first pathogenetic type of the disease determine the development of highly and moderately differentiated tumors (82.3% G1 and G2), superficial invasion of the myometrium (69.4%), high sensitivity to progestogens (80.2%), and favorable prognosis (85.6% 5-year survival rate). In patients who have the second pathogenetic type of endometrial cancer when endocrine and metabolic disturbances are absent or occult, poorly differentiated tumors arise (62.5% G3), a tendency to deep invasion of tumor into the myometrium is observed (65.7%); high frequency of metastatic spread into the pelvic lymph nodes (27.8%); decrease of sensitivity to progestogens (42.5%); and doubtful prognosis (58.8% 5-year survival rate) are noted.
Similar articles
-
Silverberg SG, Makowski EL, Roche WD. Silverberg SG, et al. Cancer. 1977 Feb;39(2):592-8. doi: 10.1002/1097-0142(197702)39:2<592::aid-cncr2820390233>3.0.co;2-o. Cancer. 1977. PMID: 837341
-
Endometrial cancer: rising incidence, detection and treatment.
Kistner RW, Krantz KE, Lebherz TB, Lewis GL Jr, Reagan JW, Smith J, Tobin JJ, Wied GL. Kistner RW, et al. J Reprod Med. 1973 Feb;10(2):53-74. J Reprod Med. 1973. PMID: 4697433
-
[Endometrial carcinoma and precursor lesions].
Djordjević B, Stanojević Z. Djordjević B, et al. Srp Arh Celok Lek. 2007 Mar-Apr;135(3-4):230-4. Srp Arh Celok Lek. 2007. PMID: 17642468 Review. Serbian.
-
Epidemiology of cancer of the endometrium.
Mahboubi E, Eyler N, Wynder EL. Mahboubi E, et al. Clin Obstet Gynecol. 1982 Mar;25(1):5-17. doi: 10.1097/00003081-198203000-00004. Clin Obstet Gynecol. 1982. PMID: 7039906 Review.
Cited by
-
Ren Z, Yang H, Wang C, Ma X. Ren Z, et al. Onco Targets Ther. 2015 Apr 9;8:769-74. doi: 10.2147/OTT.S79960. eCollection 2015. Onco Targets Ther. 2015. PMID: 25914546 Free PMC article.
-
Zhang Q, Silver M, Chen YJ, Wolf J, Hayek J, Alagkiozidis I. Zhang Q, et al. Healthcare (Basel). 2023 Dec 8;11(24):3122. doi: 10.3390/healthcare11243122. Healthcare (Basel). 2023. PMID: 38132012 Free PMC article.
-
Kalinkova L, Kajo K, Karhanek M, Wachsmannova L, Suran P, Zmetakova I, Fridrichova I. Kalinkova L, et al. Int J Mol Sci. 2020 Aug 23;21(17):6071. doi: 10.3390/ijms21176071. Int J Mol Sci. 2020. PMID: 32842533 Free PMC article.
-
Fader AN, Java J, Tenney M, Ricci S, Gunderson CC, Temkin SM, Spirtos N, Kushnir CL, Pearl ML, Zivanovic O, Tewari KS, O'Malley D, Hartenbach EM, Hamilton CA, Gould NS, Mannel RS, Rodgers W, Walker JL. Fader AN, et al. Gynecol Oncol. 2016 Dec;143(3):460-465. doi: 10.1016/j.ygyno.2016.10.016. Epub 2016 Oct 12. Gynecol Oncol. 2016. PMID: 27743738 Free PMC article. Clinical Trial.
-
Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer.
Megino-Luque C, Moiola CP, Molins-Escuder C, López-Gil C, Gil-Moreno A, Matias-Guiu X, Colas E, Eritja N. Megino-Luque C, et al. Cancers (Basel). 2020 Sep 24;12(10):2751. doi: 10.3390/cancers12102751. Cancers (Basel). 2020. PMID: 32987790 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical